found that the transcription factor RUNX1 could bind to the CSF2RB promoter to increase CSF2RB transcription, effectively reducing cell viability, invasion, metastasis, and angiogenesis and promoting neuroblastoma apoptosis in vitro and in vivo (24). Here, CSF2RB is linked to neuroblastoma.